Breaking News on Global Pharmaceutical Technology & Manufacturing

News in brief

US House aims to ID individuals behind heparin contamination


Related topics: Processing

A formal investigation to identify individuals responsible for the 2008 heparin-contamination has been launched by a US House panel.

By launching an investigation the House Energy and Commerce Committee hopes to discover exactly how heparin was contaminated and who was responsible for the adulteration.


There is reason to believe all or some of the individuals responsible for the adulteration are still actively engaged in the Chinese pharmaceutical supply chain”, said members of the panel in a letter to Margaret Hamburg, commissioner of the US Food and Drug Administration (FDA).


Documents covering heparin-related FDA inspections of Chinese sites and any information about the sources and methods of adulteration have been requested by the panel.